Provided by Tiger Trade Technology Pte. Ltd.

TELA Bio, Inc.

1.05
-0.0200-1.87%
Pre-market: 1.060.0100+0.95%08:29 EDT
Volume:137.80K
Turnover:143.24K
Market Cap:47.40M
PE:-1.35
High:1.09
Open:1.01
Low:1.00
Close:1.07
52wk High:1.56
52wk Low:0.5011
Shares:45.14M
Float Shares:21.34M
Volume Ratio:0.64
T/O Rate:0.65%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7776
EPS(LYR):-0.8300
ROE:-616.62%
ROA:-33.40%
PB:-2.99
PE(LYR):-1.27

Loading ...

TELA Bio Q2 Operating Expenses USD 23.226 Million

THOMSON REUTERS
·
Aug 11

TELA Bio Reports Second Quarter 2026 Financial Results

GlobeNewswire
·
Aug 11

TELA Bio Inc Expected to Post a Loss of 18 Cents a Share - Earnings Preview

Reuters
·
Aug 08

TELA Bio CEO, Director Heather Getz Files Initial Beneficial Ownership Statement

Reuters
·
Aug 06

Lake Street Keeps Their Buy Rating on TELA Bio (TELA)

TIPRANKS
·
Aug 04

TELA Bio Appoints Heather Getz CEO, Names Her Director

Reuters
·
Aug 04

TELA Bio Announces Appointment of Heather Getz as Chief Executive Officer and Director

THOMSON REUTERS
·
Aug 04

TELA Bio to Participate in the Canaccord Genuity 46th Annual Growth Conference

GlobeNewswire
·
Jul 30

TELA Bio Schedules Quarterly Results Conference Call and Webcast

Reuters
·
Jul 21

TELA Bio director Joseph H. Capper files initial beneficial ownership statement

Reuters
·
Jun 12

TELA Bio director Guy P. Nohra files initial beneficial ownership statement

Reuters
·
Jun 12

TELA Bio Shareholders Expand Equity Incentive Plan Authorization

TIPRANKS
·
Jun 12

TELA Bio shareholders approve 3.5 million-share increase to equity incentive plan

Reuters
·
Jun 12

Lake Street Keeps Their Buy Rating on TELA Bio (TELA)

TIPRANKS
·
May 13

Analysts Offer Insights on Healthcare Companies: Fractyl Health, Inc. (GUTS), UnitedHealth (UNH) and TELA Bio (TELA)

TIPRANKS
·
May 13

TELA Bio Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 13

TELA Bio posts modest Q1 growth, maintains 2026 outlook

TIPRANKS
·
May 13

TELA Bio Q1 net loss widens to $12.3 million; revenue rises 3% to $19.1 million

Reuters
·
May 13

TELA Bio Q1 EPS $(0.21) Misses $(0.18) Estimate, Sales $19.059M Beat $18.597M Estimate

Benzinga Earnings
·
May 13

BRIEF-TELA Bio Q1 Revenue USD 19.059 Million Vs. IBES Estimate USD 18.6 Million

Reuters
·
May 13